LISCASTOBART

UNII:	VNS9LT4XDB
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	LISCASTOBART
GSRS Full Record:	VNS9LT4XDB i

2785392-78-9
BAT-1308
BAT1308
H-gamma4 heavy chain humanized (1-447) [VH (Homo sapiens IGHV1-2*02 (79.4%) -(IGHD) -IGHJ4*01 (78.6%) L123>T (115), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG4*01, nG4m(a) CH2 L92, 12-G4v5 h P10 (CH1 (121-218), hinge 1-12 S10>P (228) (219-230), CH2 L92 (309) (231-340), CH3 (341-445), CHS (446-447)) (121-447)], (134-218')-disulfide with L-kappa light chain humanized (1'-218') [V-KAPPA (Homo sapiens IGKV3D-11*01 (85.1%) -IGKJ4*01 (100%), CDR-IMGT [10.3.9](27'-36'.54'-56'.93'-101')) (1'-111') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (157'), V101 (195')) (112'-218')]; dimer (226-226'':229-229'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1
Immunoglobulin G4 [228-proline], anti-(human programmed cell death protein 1) (human-Mus musculus monoclonal BAT1308 γ4-chain), disulfide with human-Mus musculus monoclonal BAT1308 κ-chain, dimer
Liscastobart
immunoglobulin G4-kappa, anti-[Homo sapiens PDCD1 (programmed cell death 1, PD-1, PD1, CD279)], humanized monoclonal antibody (liscastobart)
liscastobart [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LISCASTOBART

Synonyms and Mappings

Resources